# The Effect of Levcromakalim Infusion on the Cranial Arteries Over Several Hours Using a High Resolution MRA Technique in a Randomized, Double-blind Placebo-controlled Design in Healthy Volunteers.

> **NCT03609008** · NA · COMPLETED · sponsor: **Danish Headache Center** · enrollment: 20 (actual)

## Conditions studied

- Dilatation of Cranial Arteries; MMA, STA and MCA
- Headache

## Interventions

- **DRUG:** Levcromakalim
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03609008
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-26
- **Primary completion:** 2018-08-15
- **Final completion:** 2018-08-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03609008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03609008, "The Effect of Levcromakalim Infusion on the Cranial Arteries Over Several Hours Using a High Resolution MRA Technique in a Randomized, Double-blind Placebo-controlled Design in Healthy Volunteers.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03609008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*